Advanced Management of COPD + Tobacco Cardiovascular Events

Similar documents
PHARMACY PRACTICE (PHM PRAC)

ARRHYTHMIAS AND DEVICE THERAPY

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Summary of Research and Writing Activities In Cardiovascular Disease

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

(Shared Practica)

Cardiology Pharmacist. Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

Content Outline Cardiology Pharmacy Exam June 2017

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

2018 MIPS Reporting Family Medicine

Quality Measures MIPS CV Specific

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

2014 Clinical Quality Measures: Changes for the Medicaid EHR Incentive Program. Tracy McDonald Medicaid EHR Incentive Program Coordinator

Cardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center

4. Which survey program does your facility use to get your program designated by the state?

Prescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

Consensus Core Set: Cardiovascular Measures Version 1.0

Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Yes No Unknown. Major Infection Information

Torah and Science: Spiritual and Clinical Insights into Healthy Eating and Nutrition. Alan Rozanski, M.D. December 13, 2015

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

CARD 1: What is AFib and how does it relate to stroke? Talk to your patient about their condition and its connection to stroke.

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

Public Health Applications in Pharmacy

2

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

Certified Health IT Transparency and Disclosure Information 2014 Edition

Interdisciplinary Certification in Obesity and Weight Management Detailed Content Outline

Practice-Level Executive Summary Report

2016 PQRS Recommended Measures for: General/Family Practice

Meaningful Use & Million Hearts. Improving Cardiovascular Disease & Stroke Through Quality Measurements

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Manitoba Primary Care Quality Indicators Full Guide Version 3.0 Quick Reference Summary

Pharmacy Prep. Qualifying Pharmacy Review

CLINICAL PRACTICE GUIDELINE

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

2.5 Other Hematology Consult:

Day 1 10:50. Panel Discussions/Group Photo Coffee/Tea Break 11:15-11:30 (Networking) Different types of. Anesthesia. Day 2

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Disease Management. Measures At A Glance

Welcome to the Healthplex!

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

Research on medication in the geriatric health services facility Abstracts

2016 Internal Medicine Preferred Specialty Measure Set

EACTS Adult Cardiac Database

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Clinical guideline for the management of atrial fibrillation

Quality Payment Program: Cardiology Specialty Measure Set

Kaiser Permanente Complete Care. Michael H. Kanter, MD Medical Director of Quality and Clinical Analysis

Disease Management. Measures At A Glance

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH

Pharmacology 260 Online Course Schedule Summer 2015

Phar 6754 Diabetes and Metabolic Syndrome

Personalized Care One Heart at a Time

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Cardiovascular Medicine at Reading Hospital: Update May 2018

The Role of Health Information Technology in Implementing Disease Management Programs

ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE

National Asthma Educator Certification Board Detailed Content Outline

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Quality Payment Program: Cardiology Specialty Measure Set

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

2016 Physician Quality Reporting System (PQRS) GPRO Web Interface Measures List 12/18/2015

Preventive Cardiology

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Patent Foramen Ovale: Diagnosis and Treatment

CENTER FOR CONTINUING & OUTREACH EDUCATION. 30 Bergen St. ADMC 710 Newark, NJ

Syllabus and Program of the Diploma in Cardiac Pacing

Endocrinology TeleECHO Clinic Case Presentation Form

2016 General Practice/Family Practice Preferred Specialty Measure Set

RECOMMENDED COURSE ORDER

WCHQ MEASURES AT A GLANCE

Supplementary Online Content

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

Index. Note: Page numbers of article titles are in boldface type.

Student Outline. Improving Transportation Safety: Commercial Driver Medical Examiner Training CHAPTER 1. General FMCSA Information

CMS Hospital IQR Program Measure Comparison Tables FY 2018 (CY 2016) Measures Required to Meet Hospital IQR APU Requirements NHSN Submission

Diagnosis Coding. Tips, Guidelines & Common Errors. Amy Jack, Risk Adjustment Coding Auditor, RHIT, CCA, CRC

Community Leadership Council. October 9, 2018

How to prevent thrombotic diseases? Sergio Fusco, MD

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

LAC-USC Cardiology Consult Service

AMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

Public Dissemination

SOURCES: U.S. Department of Labor, Bureau of Labor Statistics; the Federal Reserve Bank of Cleveland; the Commodity Research Bureau; and U.S.

CARDIOLOGY. 3 To develop in the trainees the humanistic, moral and ethical aspects of medicine.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Transcription:

Week Day PHAR 4211 1 8/13 August 13 M - 17 8/14 T 8/15 W 8/16 Th 2 August 20-24 8/17 F 8/20 M 8/21 T 8/22 W 8/23 Th 8/24 F PHAR 4213 PHAR 4214 PAHR 4216 Introduction to course/ Team building Introduction to Course & Ambulatory Care exercise Practice Issues Aspirin for Primary Prevention of Advanced Management of COPD + Tobacco Cardiovascular Events Cessation Resistant Hypertension Management of Resistant Hypertension and Secondary Causes of Hypertension Peripheral Artery Disease Heart Failure Management Management of Hypertension in Special Populations (Elderly, Pregnancy, and Hypertensive Urgency) Advanced Heart Failure Management Part 1 Ventricular Arrhythmia Storm Advanced Heart Failure Management Part 2 ABL Cardiac Devices: Pacemakers, Impellas, ICDs, Balloon Pumps, LVADs, OH MY! Case/Activity Day Cardiac Transplantation & Pharmaceutical Considerations Exam 1 (Lectures #1-6) PHAR 4219

Week Day PHAR PHAR 4213 PHAR 4214 PAHR 4211 4216 3 8/27 TBD Lecture 7: Advanced Diabetes August 27 - M Management: DM Guidelines (including microvascular complications) 31 8/28 T Case Presentations Lecture 8: Advanced Diabetes Management: Practical Approach to Non-Insulin Therapies Part 1 8/29 Group Presentations Lecture 9: Advanced Diabetes W Management: Practical Approach to Non-Insulin Therapies Part 4 September 3-7 8/30 Th Exam 1 8/31 F 9/3 M Labor Day Holiday no classes 9/4 T Therapeutic Advances in Atrial Fibrillation Management 9/5 W Management of Post-Operative Atrial Fibrillation 9/6 Th Stroke Prevention in Atrial Fibrillation: Are there Equal 9/7 F 2 Lecture 10: Advanced Diabetes Management: Practical Approach to Insulin Therapies Part 1 Lecture 11: Advanced Diabetes Management: Practical Approach to Insulin Therapies Part 2 Case/Activity Day Exam 2 (Lectures #7-11) PHAR 4219

Week Day PHAR 4211 5 9/10 September M 10-14 9/11 T 6 September 17-21 9/12 W 9/13 Th 9/14 F 9/17 M 9/18 T 9/19 W 9/20 Th 9/21 F PHAR 4213 PHAR 4214 PAHR 4216 Heparin-induced thrombocytopenia (HIT) Lecture 12: Advanced Dyslipidemia Management: Practical Use of Lipid Guidelines Clinical Pearls Associated With The Use of Lecture 13: Advanced Dyslipidemia Management: Non- Antithrombotic Therapy Statin Therapy Post-operative care of the cardiothoracic patient Therapeutic Advances in the Management of Pulmonary Embolism ACLS management Case Presentations Group Presentations No Class: Convergence Day Exam 2 Lecture 14: Advanced Anticoagulation Management Part 1 Lecture 15: Advanced Anticoagulation Management Part 2 Lecture 16: Advanced Anticoagulation Management Part 3 Case/Activity Day Exam 3 (Lectures 12-16) PHAR 4219

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PHAR 4216 PHAR 4219 7 9/24 M Course introduction & Why Cultural Competency? September 9/25 T Defining cultural diversity and cultural competency, cultural self 24-28 9/26 W Sterotypes, generalizations 9/27 Th Cultural artobiographies 8 October 1-5 9/28 F 10/1 M Alternative healing methods 10/2 T Cultural disparities in health care 10/3 W Cultural diversity and unwanted healthcare outcomes Impact of cultural competency on the practice of pharmacy 10/4 Th Health and cultural belief models Tools to understanding the views of other cultures 10/5 F

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PHAR 4216 PHAR 4219 9 10/8 M Movie day:tbd October 8-12 10/9 T Perspectives on healthcare: religious cultures 10/10 W Guest Lecture: Muslim culture 10/11 Th Culturally responsive drug therapy plans 10/12 F

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PAHR 4216 PHAR 4219 10 October 10/15 M Career Day no classes 15-19 10/16 T Cultural health literacy and medication adherence 10/17 W Imigraiton 101: learning the culture of an imigrant 10/18 Th Medication Adherence Exercise Assessment of patient education tools/methods 11 October 22-26 10/19 F 10/22 M Group activity time 10/23 T Disabled culture (deaf community) 10/24 W Culturally appropriate communidation skills 10/25 Th Case project: communication models 10/26 F

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PAHR 4216 PHAR 4219 12 October 10/29 M Student group presentations 29 Nov 2 10/30 T Student group presentations 10/31 W Student group presentations 11/1 Th Post-cultural seareness survey & student cultural encounter discussion 13 November 5-9 11/2 F 11/5 M Introduction Antimicrobial stewardship overview 11/6 T Rapid laboratory tests and tools used in antimicrobial stewardship 11/7 W Incorporating PK- PD dosing into clinical practice 11/8 Th PCN allergy, skin testing, and de-labeling 11/9 F Course Introduction Developing Effective Portfolio/ Developing Critique skills Communication and Interprofessional Collaboration Communicating with Suicidal Patients

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PAHR 4216 PHAR 4219 14 November 12-16 11/12 M OPAT and transitions of care issues 15 November 19-23 Perfecting Patient Counseling Skills Active Listening/Empathic Responding 11/13 T CDI controversies Facilitating Patient/Pharmacist Interaction 11/14 W Vaccinations Patient Centered Communication 11/15 Th PK-PD issues in pediatric and geriatric people 11/16 F 11/19 M Antimicrobial Stewardship in Geriatric Care Centers 11/20 T Managing ID in Older Adults 11/21W Geriatric Practice Cases 11/22 Th Thanksgiving Holiday no classes 11/23 F Thanksgiving Holiday no classes Speed Counseling Exercises Assertiveness In the Healthcare Team Ethical Healthcare Communication/ Video Work Day

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PAHR 4216 PHAR 4219 16 November 26-30 11/26 M Fluorquinolones in children Patient 17 December 3-7 11/27 T CNS infections in the pediatric population I: meningitis 11/28 W CNS infections in the pediatric population II: ventriculoperitoneal shunts 11/29 Th Research updates for antifungals 11/30 F Exam 1 12/3 M Contemporary research in communityacquired pneumonia 12/4 T Hospital-acquired pneumonia 12/5 W Multi-drug resistant gram-negative pathogens: traditional agents 12/6 Th Gram-negative pathogens II: novel agents Communicating with the Aging Managing the Angry Patient Communicating with Children in the Medical Setting The Importance of Word Choice and Non- Verbal Cues In-Class critique of student video In-Class critique of student video Communicating with the Intellectually Disabled Patient Emotional Intelligence and Supporting the Patient 12/7 F Final Exam: Turn In Portfolio

Week Day PHAR 4211 PHAR 4213 PHAR 4214 PAHR 4216 PHAR 4219 18 December 12/10 M Antimicrobial dosing in obesity 10-14 12/11 T PO agents for MRSA 12/12 W IV agents for MRSA 12/13 Th Exam II 12/14 F